Latest HealthInvest Partners AB Stock Portfolio
HealthInvest Partners AB Performance:
2024 Q3: 0.18%YTD: 7.6%2023: 16.6%
Performance for 2024 Q3 is 0.18%, and YTD is 7.6%, and 2023 is 16.6%.
About HealthInvest Partners AB and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, HealthInvest Partners AB reported an equity portfolio of $212.8 Millions as of 30 Sep, 2024.
The top stock holdings of HealthInvest Partners AB are LLY, UNH, MRK. The fund has invested 12.7% of it's portfolio in ELI LILLY & CO and 9.8% of portfolio in UNITEDHEALTH GROUP INC.
The fund managers got completely rid off IQVIA HLDGS INC (IQV), MOLINA HEALTHCARE INC (MOH) and OPTION CARE HEALTH INC (OPCH) stocks. They significantly reduced their stock positions in BOSTON SCIENTIFIC CORP (BSX). HealthInvest Partners AB opened new stock positions in SUMMIT THERAPEUTICS INC (SMMT), SOLENO THERAPEUTICS INC (SLNO) and MEREO BIOPHARMA GROUP PLC (MREO). The fund showed a lot of confidence in some stocks as they added substantially to HARMONY BIOSCIENCES HLDGS IN (HRMY), ALKERMES PLC (ALKS) and MERSANA THERAPEUTICS INC (MRSN).
The top stock holdings of HealthInvest Partners AB are LLY, UNH, MRK. The fund has invested 12.7% of it's portfolio in ELI LILLY & CO and 9.8% of portfolio in UNITEDHEALTH GROUP INC.
The fund managers got completely rid off IQVIA HLDGS INC (IQV), MOLINA HEALTHCARE INC (MOH) and OPTION CARE HEALTH INC (OPCH) stocks. They significantly reduced their stock positions in BOSTON SCIENTIFIC CORP (BSX). HealthInvest Partners AB opened new stock positions in SUMMIT THERAPEUTICS INC (SMMT), SOLENO THERAPEUTICS INC (SLNO) and MEREO BIOPHARMA GROUP PLC (MREO). The fund showed a lot of confidence in some stocks as they added substantially to HARMONY BIOSCIENCES HLDGS IN (HRMY), ALKERMES PLC (ALKS) and MERSANA THERAPEUTICS INC (MRSN).
HealthInvest Partners AB Annual Return Estimates Vs S&P 500
Our best estimate is that HealthInvest Partners AB made a return of 0.18% in the last quarter. In trailing 12 months, it's portfolio return was 13.99%.
New Buys
| Ticker | $ Bought |
|---|---|
| summit therapeutics inc | 1,883,680 |
| soleno therapeutics inc | 1,332,430 |
| mereo biopharma group plc | 822,000 |
New stocks bought by HealthInvest Partners AB
Additions
| Ticker | % Inc. |
|---|---|
| harmony biosciences hldgs in | 335 |
| alkermes plc | 243 |
| mersana therapeutics inc | 191 |
| cabaletta bio inc | 162 |
| neurocrine biosciences inc | 156 |
| intra-cellular therapies inc | 135 |
| immunocore hldgs plc | 127 |
| ionis pharmaceuticals inc | 103 |
Additions to existing portfolio by HealthInvest Partners AB
Reductions
| Ticker | % Reduced |
|---|---|
| boston scientific corp | -0.36 |
HealthInvest Partners AB reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| macrogenics inc | -609,479 |
| option care health inc | -1,506,740 |
| morphic hldg inc | -688,179 |
| iqvia hldgs inc | -2,956,780 |
| molina healthcare inc | -2,824,350 |
HealthInvest Partners AB got rid off the above stocks
Sector Distribution
HealthInvest Partners AB has about 95.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 95.8 |
| Others | 4.2 |
Market Cap. Distribution
HealthInvest Partners AB has about 72.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MEGA-CAP | 41.3 |
| LARGE-CAP | 31.1 |
| MID-CAP | 15.8 |
| SMALL-CAP | 8 |
| UNALLOCATED | 3.3 |
Stocks belong to which Index?
About 85.5% of the stocks held by HealthInvest Partners AB either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 65.3 |
| RUSSELL 2000 | 20.2 |
| Others | 14.5 |
HealthInvest Partners AB Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of HealthInvest Partners AB
HealthInvest Partners AB has 36 stocks in it's portfolio. About 61.4% of the portfolio is in top 10 stocks. CRBP proved to be the most loss making stock for the portfolio. UNH was the most profitable stock for HealthInvest Partners AB last quarter.
Last Reported on: 12 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 4.13 | 44,486 | 8,785,100 | added | 24.9 | ||
| ABC | cencora inc | 3.87 | 36,544 | 8,225,320 | added | 20.53 | ||
| ACLX | arcellx inc | 1.58 | 40,230 | 3,359,610 | added | 78.83 | ||
| ALKS | alkermes plc | 3.11 | 236,610 | 6,622,710 | added | 243 | ||
| AMGN | amgen inc | 4.39 | 28,965 | 9,332,810 | added | 4.99 | ||
| AUTL | autolus therapeutics plc | 0.76 | 442,423 | 1,606,000 | added | 95.64 | ||
| BBIO | bridgebio pharma inc | 0.64 | 53,432 | 1,360,380 | unchanged | 0.00 | ||
| BSX | boston scientific corp | 4.18 | 106,172 | 8,897,210 | reduced | -0.36 | ||
| CABA | cabaletta bio inc | 0.37 | 168,522 | 795,424 | added | 162 | ||
| CAH | cardinal health inc | 1.43 | 27,500 | 3,039,300 | unchanged | 0.00 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.68 | 69,573 | 1,435,290 | added | 77.94 | ||
| DXCM | dexcom inc | 1.69 | 53,757 | 3,603,870 | added | 55.89 | ||
| EW | edwards lifesciences corp | 1.13 | 36,505 | 2,408,960 | unchanged | 0.00 | ||
| FOLD | amicus therapeutics inc | 1.38 | 275,472 | 2,942,040 | added | 85.87 | ||
| HRMY | harmony biosciences hldgs in | 2.86 | 151,875 | 6,075,000 | added | 335 | ||
| IMCR | immunocore hldgs plc | 0.79 | 54,060 | 1,682,890 | added | 127 | ||
| IONS | ionis pharmaceuticals inc | 1.56 | 82,691 | 3,312,600 | added | 103 | ||
| IQV | iqvia hldgs inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ITCI | intra-cellular therapies inc | 2.91 | 84,578 | 6,188,570 | added | 135 | ||
| KRYS | krystal biotech inc | 0.79 | 9,202 | 1,675,040 | added | 20.7 | ||